PERFORMANT FINANCIAL CORP (PFMT)

US71377E1055 - Common Stock

2.78  -0.05 (-1.77%)

After market: 2.78 0 (0%)

Fundamental Rating

3

Taking everything into account, PFMT scores 3 out of 10 in our fundamental rating. PFMT was compared to 84 industry peers in the Commercial Services & Supplies industry. While PFMT seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, PFMT is valued expensive at the moment.



1

1. Profitability

1.1 Basic Checks

In the past year PFMT has reported negative net income.
In the past year PFMT had a positive cash flow from operations.
PFMT had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: PFMT reported negative operating cash flow in multiple years.

1.2 Ratios

Looking at the Return On Assets, with a value of -7.59%, PFMT is doing worse than 74.70% of the companies in the same industry.
The Return On Equity of PFMT (-9.31%) is worse than 65.06% of its industry peers.
Industry RankSector Rank
ROA -7.59%
ROE -9.31%
ROIC N/A
ROA(3y)-7.17%
ROA(5y)-10.38%
ROE(3y)-9.84%
ROE(5y)-22.57%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for PFMT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

6

2. Health

2.1 Basic Checks

PFMT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PFMT has more shares outstanding
PFMT has more shares outstanding than it did 5 years ago.
PFMT has a better debt/assets ratio than last year.

2.2 Solvency

PFMT has an Altman-Z score of 7.49. This indicates that PFMT is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of PFMT (7.49) is better than 92.77% of its industry peers.
PFMT has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
PFMT has a Debt to Equity ratio of 0.06. This is amongst the best in the industry. PFMT outperforms 80.72% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 7.49
ROIC/WACCN/A
WACC9.23%

2.3 Liquidity

A Current Ratio of 3.21 indicates that PFMT has no problem at all paying its short term obligations.
The Current ratio of PFMT (3.21) is better than 85.54% of its industry peers.
PFMT has a Quick Ratio of 3.21. This indicates that PFMT is financially healthy and has no problem in meeting its short term obligations.
PFMT has a better Quick ratio (3.21) than 89.16% of its industry peers.
Industry RankSector Rank
Current Ratio 3.21
Quick Ratio 3.21

4

3. Growth

3.1 Past

PFMT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -25.00%.
Looking at the last year, PFMT shows a small growth in Revenue. The Revenue has grown by 4.18% in the last year.
PFMT shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.09% yearly.
EPS 1Y (TTM)-25%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2QN/A
Revenue 1Y (TTM)4.18%
Revenue growth 3Y-9.98%
Revenue growth 5Y-6.09%
Revenue growth Q2Q11.38%

3.2 Future

The Earnings Per Share is expected to grow by 70.82% on average over the next years. This is a very strong growth
Based on estimates for the next years, PFMT will show a quite strong growth in Revenue. The Revenue will grow by 13.26% on average per year.
EPS Next Y28.6%
EPS Next 2Y70.82%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.9%
Revenue Next 2Y13.26%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PFMT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PFMT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PFMT's earnings are expected to grow with 70.82% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y70.82%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

PFMT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PERFORMANT FINANCIAL CORP

NASDAQ:PFMT (5/3/2024, 3:30:00 PM)

After market: 2.78 0 (0%)

2.78

-0.05 (-1.77%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap213.84M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.59%
ROE -9.31%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.15
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.21
Quick Ratio 3.21
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-25%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y28.6%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)4.18%
Revenue growth 3Y-9.98%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y